Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
New York marijuana regulators on Friday gave the formal thumbs up to six of the state's 10 licensed medical marijuana companies – most of which are large multistate operators – to begin adult-use cannabis sales on Dec. 29, precisely one year after recreational sales were launched in the Empire State.
The half dozen that got the green light from the state Cannabis Control Board include:
Ultimately those six companies will be permitted to set up co-located recreational sales at up to three of their existing medical dispensaries, but for the time being, each was only approved for a single shop that can open by the end of the month.
Four other New York medical marijuana companies weren't mentioned during the CCB meeting, but technically they are eligible to apply for transition into the recreational market, including:
The CCB also approved new medical-only dispensary locations for both Citiva and Fiorello at Friday's meeting, giving the former permission to open a dispensary in Ithaca and the latter for one on Long Island.
"The registered organizations being considered today have submitted the required materials to transition, including a community impact plan, medical patient prioritization plan, and an energy and environmental plan," Damian Fagon, chief equity officer at the Office of Cannabis Management, told the board Friday.
"We are excited to have ‘registered organizations‘ enter the market, while continuing to prioritize and expand offerings to medical patients," Fagon said, adding that the OCM recommended the allowance of all six so-called "R.O.'s."
Posted In: ACRHF CCHWF CNPOF CRLBF CSE:ACRG CSE:CL CSE:CURA CSE:GTII CSE:IAN CSE:MMEN CSE:RIV CSE:VREO CURLF GTBIF ITHUF MMNFF VREOF